Neha Mehta-Shah, MD, MSCI - Washington ...

Dr. Neha Mehta-shah, M.D.

Claim this profile

Washington University School of Medicine

Expert in Lymphoma
Studies Mycosis Fungoides/Sezary Syndrome
19 reported clinical trials
34 drugs studied

About Neha Mehta-shah, M.D.

Education:

  • MD from Feinberg School of Medicine, Northwestern University, Chicago, IL (2005-2009).
  • Masters of Science in Clinical Investigation (MSCI) from Washington University in St. Louis, MO (2016-2019).
  • BA in Psychology (Cum Laude) from Northwestern University, Evanston, IL (2002-2005).

Experience:

  • Assistant Professor of Medicine at Washington University in St. Louis, specializing in peripheral and cutaneous T-cell lymphomas.
  • Fellow in Hematology/Oncology at Memorial Sloan Kettering Cancer Center, New York, NY (2013-2016).
  • Chief Medical Resident at Memorial Sloan Kettering Cancer Center, New York, NY (2012-2013).
  • Resident in Internal Medicine at New York Presbyterian-Weill Cornell Medical Center, New York, NY (2009-2012).

Area of expertise

1Lymphoma
Global Leader
Neha Mehta-shah, M.D. has run 15 trials for Lymphoma. Some of their research focus areas include:
Stage IV
Stage II
Stage III
2Mycosis Fungoides/Sezary Syndrome
Neha Mehta-shah, M.D. has run 5 trials for Mycosis Fungoides/Sezary Syndrome. Some of their research focus areas include:
Stage II
Stage III
Stage IV

Affiliated Hospitals

Image of trial facility.
Washington University School Of Medicine
Image of trial facility.
Siteman Cancer Center At West County Hospital

Clinical Trials Neha Mehta-shah, M.D. is currently running

Image of trial facility.

CFT7455

for Lymphoma

The purpose of this study is to characterize the safety, tolerability, pharmacokinetics, pharmacodynamics, and antitumor activity of oral cemsidomide (also known as CFT7455) administered at different dosages in subjects with Relapsed/Refractory (r/r) Non-Hodgkin's Lymphoma (NHL) or Multiple Myeloma (MM). Cemsidomide may be administered as a single agent and, in MM only, in combination with oral dexamethasone.
Recruiting1 award Phase 1 & 210 criteria
Image of trial facility.

Lenalidomide + Nivolumab

for Lymphoma

This trial tests a combination of drugs to treat a rare brain cancer. The treatment aims to starve the tumor, boost the immune system, and stop cancer cells from growing. It targets patients with primary CNS lymphoma who may not respond well to standard treatments.
Recruiting1 award Phase 119 criteria

More about Neha Mehta-shah, M.D.

Clinical Trial Related4 years of experience running clinical trials · Led 19 trials as a Principal Investigator · 8 Active Clinical Trials
Treatments Neha Mehta-shah, M.D. has experience with
  • Nivolumab
  • Rituximab
  • Duvelisib
  • Mosunetuzumab
  • CHP
  • Polatuzumab Vedotin
Breakdown of trials Neha Mehta-shah, M.D. has run
Lymphoma
Mycosis Fungoides/Sezary Syndrome
Hematological Tumors
Sézary Syndrome
Non-Hodgkin's Lymphoma

Other Doctors you might be interested in

Justin Barnes, M.D.Washington University School of Medicine
Thomas Maddox, MDWashington University School of Medicine
Angela Hirbe, M.D., Ph.D.Washington University School of Medicine

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Neha Mehta-shah, M.D. specialize in?
Neha Mehta-shah, M.D. focuses on Lymphoma and Mycosis Fungoides/Sezary Syndrome. In particular, much of their work with Lymphoma has involved Stage IV patients, or patients who are Stage II.
Is Neha Mehta-shah, M.D. currently recruiting for clinical trials?
Yes, Neha Mehta-shah, M.D. is currently recruiting for 8 clinical trials in Saint Louis Missouri. If you're interested in participating, you should apply.
Are there any treatments that Neha Mehta-shah, M.D. has studied deeply?
Yes, Neha Mehta-shah, M.D. has studied treatments such as Nivolumab, Rituximab, Duvelisib.
What is the best way to schedule an appointment with Neha Mehta-shah, M.D.?
Apply for one of the trials that Neha Mehta-shah, M.D. is conducting.
What is the office address of Neha Mehta-shah, M.D.?
The office of Neha Mehta-shah, M.D. is located at: Washington University School of Medicine, Saint Louis, Missouri 63110 United States. This is the address for their practice at the Washington University School of Medicine.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top